Liraglutide treatment significantly decreased insulin receptor aberrations in conjunction with a concomitant decrease in amyloid plaque load and a highly significant reduction in astrocytosis and microglial number associated with both plaques and IR pathology ( 214 ).
← all excerpts
The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer's disease.
1
—
—